Wellgistics receives Nasdaq deficiency notice; forms JV with KareRx hub

Wellgistics Health, Inc.

Received Nasdaq deficiency letter on Apr 13, 2026 for failing minimum $2.5M stockholders' equity; equity was -$12.4M.
Entered JV with Kare Rx Hub, forming LLC with Wellgistics owning 51%, Kare Hub 49%.
Will pay $2M in unregistered common stock (1.5M shares at closing) for transferred IP and assets.
JV aims to integrate technology platforms to reach 200,000+ patient lives across pharmaceutical and provider networks.

item 3.01 item 1.01 item 3.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Wellgistics Health, Inc. entered into Collaboration Agreement with Kare Rx Hub, LLC, Kare Pharmtech, LLC, and Healthstar Technologies, LLC valued at $2,000,000 (effective 2026-04-13).

Action: entry
Agreement: collaboration
Counterparty: Kare Rx Hub, LLC, Kare Pharmtech, LLC, and Healthstar Technologies, LLC
Value: $2,000,000
Effective: 2026-04-13

Exact text from the filing

On April 13, 2026, Wellgistics Health, Inc. (the “Company”) entered into a Collaboration Agreement (the “Collaboration Agreement”) with Kare Rx Hub, LLC (“Kare Hub”), Kare Pharmtech, LLC (“Kare Pharmtech”), and Healthstar Technologies, LLC (“Healthstar”), pursuant to which the parties agreed to collaborate through a newly formed limited liability company structure.

View on SEC.gov

84 material agreements filed in the last 30 days. Browse all material agreements →

Wellgistics Health, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-018326

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.